Capecitabin Helvepharm 150 mg
Capecitabin Helvepharm 150 mg is a medicine authorised by Swissmedic under authorisation number 62835. The authorisation holder is Helvepharm AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 18 July 2013 and the authorisation is valid without a time limit. ATC code L01BC06 places the medicine in the group Antineoplastic agents.
| Authorisation number | 62835 |
|---|---|
| Name | Capecitabin Helvepharm 150 mg |
| Full name | Capecitabin Helvepharm 150 mg, Filmtabletten |
| Authorisation holder | Helvepharm AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01BC06 |
| First authorisation | 18 July 2013 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Capecitabin Helvepharm 150 mg, Filmtabletten | A | 18 July 2013 |
| 2 | Capecitabin Helvepharm 500 mg, Filmtabletten | A | 18 July 2013 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 5 | 60 | Tablette(n) | L01BC06 | 07.16.1. | A |
| 6 | 120 | Tablette(n) | L01BC06 | 07.16.1. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Capecitabin Helvepharm 150 mg authorised in Switzerland?
Yes. Capecitabin Helvepharm 150 mg is authorised by Swissmedic under authorisation number 62835, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Capecitabin Helvepharm 150 mg have?
Capecitabin Helvepharm 150 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Capecitabin Helvepharm 150 mg?
The authorisation holder is Helvepharm AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.